Skip to main content
OpenTrials
Completed

NCT Number: NCT04944667

Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve Replacement

This study sought to evaluate the impact of Virtual Reality (VR) tools in procedural planning of transcatheter aortic valve replacement (TAVR).

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CentroMT (Centro Médico Teknon)

Barcelona, 08022, Spain

About this study

A prospective study involving 11 patients referred for TAVR was conducted. A multidetector computed tomography (MDCT) was used to acquire and segment the anatomy of the access route and landing zone. From the information obtained with the MDCT in DICOM format, the investigators built a virtual platform (VisuaMed, Teacher Team. Valencia. Spain) that contains all the clinical information of the patients and a virtualized model of their anatomy. Wearing VR devices, the professional was able to "walk inside " the anatomy in an interactive and immersive way. Decisions after the evaluation of routine clinical images were compared with those after experience with VR models and intraprocedural findings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Severe aortic stenosis considered for TAVR procedure at a single Institution

Exclusion criteria

  • None

Treatment and study plan

TAVR planning

Diagnostic Test

TAVR planning without VR vs after VR

Primary outcomes

  1. TAVR procedure planning (prosthesis size, implant technique requirements, potential risks)

    Time frame: Baseline

    Does the TAVR procedure planning change after VR?

Sponsors and collaborators

Lead sponsor

Centro Medico Teknon

Other

Collaborators

  • Techer Team SL. Valencia. Spain

Registry information

Official study title

Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve Replacement (TAVR)

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 29, 2021
Registry last updated
Mar 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.